Blue Trust’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.5K Sell
70
-212
-75% -$46.2K ﹤0.01% 1585
2026
Q2
$55K Sell
282
-62
-18% -$12.8K ﹤0.01% 1310
2026
Q1
$77.2K Sell
344
-118
-26% -$29.4K ﹤0.01% 1138
2025
Q4
$111K Buy
462
+5
+1% +$1.28K ﹤0.01% 1004
2025
Q3
$125K Sell
457
-19
-4% -$5.19K ﹤0.01% 978
2025
Q2
$123K Sell
476
-215
-31% -$51.3K ﹤0.01% 962
2025
Q1
$155K Buy
691
+239
+53% +$55.8K ﹤0.01% 809
2024
Q4
$103K Sell
452
-522
-54% -$126K ﹤0.01% 928
2024
Q3
$186K Buy
974
+762
+359% +$170K ﹤0.01% 896
2024
Q2
$42K Buy
212
+137
+183% +$27.8K ﹤0.01% 1320
2024
Q1
$14.9K Buy
75
+26
+53% +$4.76K ﹤0.01% 1335
2023
Q4
$7K Sell
49
-88
-64% -$13.5K ﹤0.01% 1721
2023
Q3
$30K Buy
137
+18
+15% +$3.26K ﹤0.01% 1039
2023
Q2
$26K Sell
119
-95
-44% -$21.2K ﹤0.01% 952
2023
Q1
$45K Buy
214
+55
+35% +$11.9K ﹤0.01% 1078
2022
Q4
$35K Buy
159
+67
+73% +$14.7K ﹤0.01% 1075
2022
Q3
$20K Buy
92
+7
+8% +$1.59K ﹤0.01% 1097
2022
Q2
$21K Buy
+85
New +$18.1K ﹤0.01% 938

Other funds holding RMD

Blue Trust's RMD Position: Q3 2026 in Review

Blue Trust reduced its ResMed (RMD) stake by 75% in Q3 2026, selling an estimated $46.2K and leaving 70 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Blue Trust first reported a position in RMD in Q2 2022 and has held it in 18 quarters since. The position peaked at $186K in Q3 2024. 789 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Blue Trust held 70 shares of ResMed worth $15.5K as of Q3 2026.
  • Blue Trust sold 212 ResMed shares in Q3 2026, an estimated $46.2K.
  • ResMed made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1585 holding.
  • Blue Trust first reported a position in ResMed in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's ResMed position peaked at $186K in Q3 2024.
  • 789 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.